Cargando…
Race in a bottle : the story of BiDil and racialized medicine in a post-genomic age /
Approved by the FDA in 2005 as the first drug with a race-specific indication on its label, BiDil was touted as a pathbreaking therapy to treat heart failure in black patients. Kahn reveals that, at the most basic level, BiDil became racial through legal maneuvering and commercial pressure as much a...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York :
Columbia University Press,
2012.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ii 4500 | ||
|---|---|---|---|
| 001 | JSTOR_ocn818814876 | ||
| 003 | OCoLC | ||
| 005 | 20231005004200.0 | ||
| 006 | m o d | ||
| 007 | cr unu|||||||| | ||
| 008 | 121124t20122013nyu ob 001 0 eng d | ||
| 040 | |a EBLCP |b eng |e rda |e pn |c EBLCP |d OCLCQ |d YDXCP |d N$T |d OCLCO |d TEFOD |d JSTOR |d OCLCQ |d OCLCO |d E7B |d CUS |d NUI |d CNSPO |d IDEBK |d OCLCQ |d SOI |d TEFOD |d DEBBG |d RECBK |d OCLCQ |d AGLDB |d CUI |d OCLCQ |d MERUC |d OCLCQ |d IOG |d DEGRU |d EZ9 |d CUS |d OCLCF |d HCO |d VTS |d USU |d CUY |d OCLCA |d ICG |d ZCU |d OCLCO |d REC |d AU@ |d OCLCQ |d LVT |d TKN |d STF |d LEAUB |d DKC |d OCLCO |d OCLCQ |d OCLCO |d M8D |d OCL |d OCLCQ |d OCLCA |d MM9 |d OCLCO |d LOA |d INT |d K6U |d VT2 |d U3W |d CNCEN |d WYU |d G3B |d S8J |d S9I |d D6H |d TUHNV |d SFB |d OCLCQ |d OCL |d OCLCO | ||
| 019 | |a 826438550 |a 870962918 |a 899002198 |a 979626630 |a 992861466 |a 1042321453 | ||
| 020 | |a 9780231531276 |q (electronic bk.) | ||
| 020 | |a 0231531273 |q (electronic bk.) | ||
| 020 | |z 9780231162982 | ||
| 024 | 7 | |a 10.7312/kahn16298 |2 doi | |
| 029 | 1 | |a AU@ |b 000053019457 | |
| 029 | 1 | |a CHBIS |b 011058280 | |
| 029 | 1 | |a CHVBK |b 498840093 | |
| 029 | 1 | |a DEBBG |b BV042795315 | |
| 029 | 1 | |a DEBBG |b BV042998643 | |
| 029 | 1 | |a DEBSZ |b 47797970X | |
| 029 | 1 | |a GBVCP |b 100371692X | |
| 029 | 1 | |a DKDLA |b 820120-katalog:999926626705765 | |
| 035 | |a (OCoLC)818814876 |z (OCoLC)826438550 |z (OCoLC)870962918 |z (OCoLC)899002198 |z (OCoLC)979626630 |z (OCoLC)992861466 |z (OCoLC)1042321453 | ||
| 037 | |a 22573/ctt3ckw8p |b JSTOR | ||
| 037 | |a B753A4D6-018C-4925-9FF7-BAC20889F3E2 |b OverDrive, Inc. |n http://www.overdrive.com | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a RM666.H7 |b .K34 2012 | |
| 060 | 4 | |a QV 151 | |
| 072 | 7 | |a HEA |x 039080 |2 bisacsh | |
| 072 | 7 | |a MED |x 010000 |2 bisacsh | |
| 072 | 7 | |a MED050000 |2 bisacsh | |
| 072 | 7 | |a POL028000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.12906108996073 |
| 084 | |a CC 7264 |2 rvk |0 (DE-625)rvk/17679: | ||
| 049 | |a UAMI | ||
| 100 | 1 | |a Kahn, Jonathan, |e author. | |
| 245 | 1 | 0 | |a Race in a bottle : |b the story of BiDil and racialized medicine in a post-genomic age / |c Jonathan Kahn. |
| 264 | 1 | |a New York : |b Columbia University Press, |c 2012. | |
| 264 | 4 | |c ©2013 | |
| 300 | |a 1 online resource (329 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 588 | 0 | |a Print version record. | |
| 504 | |a Includes bibliographical references (pages 247-301) and index. | ||
| 505 | 0 | |a Organizing race : paths toward the re-biologization of race in modern biomedical research, practice, and product development -- The birth of BiDil : how a drug becomes "ethnic" -- Statistical mischief and racial frames for drug development and marketing -- Capitalizing (on) race in drug development -- Race-ing patents/patenting race : an emerging political geography of intellectual property in biotechnology -- Not fade away : the persistence of race and the politics of the "meantime" in pharmacogenomics -- From disparity to difference : the politics of racial medicine. | |
| 520 | |a Approved by the FDA in 2005 as the first drug with a race-specific indication on its label, BiDil was touted as a pathbreaking therapy to treat heart failure in black patients. Kahn reveals that, at the most basic level, BiDil became racial through legal maneuvering and commercial pressure as much as through medical understandings of how the drug worked. He examines the legal and calls for a more reasoned approach to using race in biomedical research and practice. | ||
| 546 | |a In English. | ||
| 590 | |a JSTOR |b Books at JSTOR Demand Driven Acquisitions (DDA) | ||
| 590 | |a JSTOR |b Books at JSTOR Evidence Based Acquisitions | ||
| 590 | |a JSTOR |b Books at JSTOR All Purchased | ||
| 650 | 0 | |a Hydralazine |x Development |x History. | |
| 650 | 0 | |a Health and race. | |
| 650 | 0 | |a African Americans |x Medical care. | |
| 650 | 0 | |a Pharmacogenetics |x Social aspects. | |
| 650 | 0 | |a Pharmaceutical industry |x Political aspects |z United States. | |
| 650 | 0 | |a African Americans. | |
| 650 | 0 | |a Pharmacogenetics. | |
| 650 | 1 | 2 | |a Hydralazine |x therapeutic use |
| 650 | 2 | 2 | |a Isosorbide Dinitrate |x therapeutic use |
| 650 | 2 | 2 | |a Heart Failure |x drug therapy |
| 650 | 2 | 2 | |a Heart Failure |x ethnology |
| 650 | 2 | 2 | |a Black or African American |
| 650 | 2 | 2 | |a Pharmacogenetics |
| 651 | 2 | |a United States | |
| 650 | 6 | |a Santé et race. | |
| 650 | 6 | |a Noirs américains |x Soins médicaux. | |
| 650 | 6 | |a Pharmacogénétique |x Aspect social. | |
| 650 | 6 | |a Industrie pharmaceutique |x Aspect politique |z États-Unis. | |
| 650 | 6 | |a Noirs américains. | |
| 650 | 6 | |a Pharmacogénétique. | |
| 650 | 7 | |a African American. |2 aat | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x Heart. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Cardiology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Ethics. |2 bisacsh | |
| 650 | 7 | |a Pharmacogenetics |2 fast | |
| 650 | 7 | |a African Americans |2 fast | |
| 650 | 7 | |a African Americans |x Medical care |2 fast | |
| 650 | 7 | |a Health and race |2 fast | |
| 651 | 7 | |a United States |2 fast | |
| 655 | 0 | |a Electronic books. | |
| 655 | 7 | |a History |2 fast | |
| 776 | 0 | 8 | |i Print version: |a Kahn, Jonathan. |t Race in a bottle. |d New York : Columbia University Press, [2013] |z 9780231162982 |w (DLC) 2012023167 |w (OCoLC)794366478 |
| 856 | 4 | 0 | |u https://jstor.uam.elogim.com/stable/10.7312/kahn16298 |z Texto completo |
| 938 | |a De Gruyter |b DEGR |n 9780231531276 | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL1028090 | ||
| 938 | |a ebrary |b EBRY |n ebr10975960 | ||
| 938 | |a EBSCOhost |b EBSC |n 502988 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n cis30216359 | ||
| 938 | |a Recorded Books, LLC |b RECE |n rbeEB00640205 | ||
| 938 | |a YBP Library Services |b YANK |n 9249384 | ||
| 994 | |a 92 |b IZTAP | ||